BioWorld

April 16, 2008

View Archived Issues

Roche Buying Privately Held Piramed for $160M Up Front

Less than five years after its founding, privately held Piramed Ltd. agreed to be acquired by Roche Holdings Ltd. for $160 million up front in one of the few recent deals to stand out in the slumping UK biotech sector. (BioWorld Today) Read More

Genentech, Biogen Idec's Rituxan Misses Lofty Mark in MS Trial

Read More

At AACR, Discussions on a Faster Road to Beacons

Read More

Aileron Raises $10M to Pursue Stapled Peptides Therapeutics

Read More

Other News To Note

Read More

AACR Roundup

Read More

Clinic Roundup

Read More